|
［26］ Lo JA, Kawakubo M, Juneja VR, et al. Epitope spreading towardwild ⁃ type melanocyte ⁃ lineage antigens rescues suboptimal immune checkpoint blockade responses［J］. Sci Transl Med,2021,13（581）: eabd8636. doi: 10.1126/scitranslmed.abd8636. ［27］ Hua C, Boussemart L, Mateus C, et al. Association of vitiligo with tumor response in patients with metastatic melanomatreated with pembrolizumab［J］. JAMA Dermatol, 2016,152（1）:45⁃51. doi: 10.1001/jamadermatol.2015.2707. ［28］ Herzberg B, Fisher DE. Metastatic melanoma andimmunotherapy［J］. Clin Immunol, 2016,172:105 ⁃ 110. doi: 10.1016/j.clim.2016.07.006. ［29］ Turk MJ, Guevara ⁃ Patiño JA, Rizzuto GA, et al. Concomitanttumor immunity to a poorly immunogenic melanoma is preventedby regulatory T cells［J］. J Exp Med, 2004,200（6）:771⁃782. doi:10.1084/jem.20041130. ［30］ Xu Z, Chen D, Hu Y, et al. Anatomically distinct fibroblastsubsets determine skin autoimmune patterns［J］. Nature, 2022,601（7891）:118⁃124. doi: 10.1038/s41586⁃021⁃04221⁃8. |
|
|
